Ledger.Open graph →
SEC Form D · filed December 12, 2017

Trillium Therapeutics Inc

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MISSISSAUGA, Ontario, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

James Parsons · Mississauga, Ontario, CanadaExecLuke Beshar · Mississauga, Ontario, CanadaDirectorNiclas Stiernholm · Toronto, Ontario, CanadaExec · DirectorRobert Uger · Toronto, Ontario, CanadaExecCalvin Stiller · Ottawa, Ontario, CanadaDirectorHelen Tayton-Martin · Mississauga, Ontario, CanadaDirectorRobert Kirkman · Mississauga, Ontario, CanadaDirectorPenka Petrova · Toronto, Ontario, CanadaExecThomas Reynolds · Mississauga, Ontario, CanadaDirectorEric Sievers · Mississauga, Ontario, CanadaExecMichael Moore · Irvine, CADirectorHenry Frieson · Mississauga, Ontario, CanadaDirectorNiclas Stiernholm · Mississauga, Ontario, CanadaExec · DirectorRobert Uger · Mississauga, Ontario, CanadaExecCalvin Stiller · Mississauga, Ontario, CanadaDirectorJames Parsons · MISSISSAUGA, Ontario, CanadaExecHelen Tayton-Martin · Mississauga, Ontario, CanadaDirectorRobert Kirkman · Mississauga, Ontario, CanadaDirectorPenka Petrova · Mississauga, Ontario, CanadaExecThomas Reynolds · Mississauga, Ontario, CanadaDirectorEric Sievers · Mississauga, Ontario, CanadaExecMichael Moore · Fife, WADirectorHenry Frieson · Mississauga, Ontario, CanadaDirectorLuke Beshar · Mississauga, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗